Definitive Contract 75D30121C10058
Award Date 11/13/20
Potential Completion Date 3/5/22
Potential Value $25M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Secaucus, NJ 07094, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
- Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
- This is a $93,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The contract is for the delivery of de-identified nasopharyngeal specimens, with a period of performance through August 13, 2026. This award does not have a set-aside designation. Quest Diagnostics has a long history of supporting federal agencies, including providing lab services for the CDC's...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...
- This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
- The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery Indefinite Quantity (IDIQ) contract to Quest Diagnostics Incorporated, a provider of diagnostic information services, for a "Test Surge and Data Sharing" program. The $493,118 contract has a period of performance through September 2025 and is a time and materials type contract. This IDIQ vehicle allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an...
- The Centers for Disease Control and Prevention (CDC) awarded a $8,587,890.00 firm fixed price definitive contract to Quest Diagnostics Nichols Institute, doing business as Quest Diagnostics, for genomic sequencing services. The contract supports the CDC's disease prevention and health promotion efforts through genomic surveillance of viruses like COVID-19. This contract does not have a set-aside designation. Quest Diagnostics Nichols Institute, a subsidiary of the parent company Quest...
- This is a federal contract award to Quest Diagnostics Incorporated, a large, for-profit diagnostic information services provider, for a COVID-19 self-swab and point-of-care testing public-private partnership. The contract, valued at $10,360,593.00, was awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, on April 4, 2020, with a final completion date of February 10, 2021. The contract is a definitive contract with a fixed-price incentive pricing type....